{"id":"W2038349091","doi":"10.1016/j.ejca.2011.09.002","title":"Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Sunitinib; Medicine; Internal medicine; Cancer research; Oncology; Cancer; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001164226,0.001731389,0.002807991,0.000445194,0.000518425,0.001065251,0.0006871357,0.001267529,0.00446111],"category_scores_gemma":[0.0007951657,0.0005369016,0.001736818,0.0003464245,0.0008264757,0.001109858,0.0003312739,0.003408301,0.001009789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001114059,"about_ca_system_score_gemma":0.001352616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001434086,"about_ca_topic_score_gemma":0.003932834,"domain_scores_codex":[0.9996774,0.0001381108,0.0000120231,0.00005360274,0.00002104839,0.00009772305],"domain_scores_gemma":[0.9994898,0.00008949999,0.00007101597,0.00003002082,0.000024668,0.0002950092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8760471,0.01989895,0.00346579,0.00065932,0.001440458,0.0003113293,0.000198608,0.003117944,0.01745993,0.0003677579,0.006009395,0.07102334],"study_design_scores_gemma":[0.8011681,0.1822848,0.00885591,0.0000295033,0.0004053633,0.0003248003,0.00005935995,0.001674143,0.001967971,0.0002651403,0.002929246,0.00003562709],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918995,0.002637454,0.0003761703,0.001009579,0.0003131022,0.0007584097,0.0009449208,0.0001389836,0.001921846],"genre_scores_gemma":[0.9911006,0.001493549,0.000755273,0.0007978163,0.0002219956,0.0008427592,0.001846138,0.00003390417,0.002907932],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00446111,"threshold_uncertainty_score":0.01492387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02376342824592086,"score_gpt":0.2733685222410839,"score_spread":0.249605093995163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}